Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
Blood|January 24, 2020
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphomaRegina Wan Ju Wong, Tze King Tan, Stella Amanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infectionKiyoaki Ito, Yasuhito Tanaka, Etsuro Orito, et al.
Cancer Science|June 8, 2018
Current state of therapeutic development for rare cancers in Japan, and proposals for improvementAkira Kawai, Toshio Goto, Tatsuhiro Shibata, et al.
Journal of Virological Methods|May 22, 2003
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase supportHideaki Kato, Etsuro Orito, Fuminaka Sugauchi, et al.
International Journal of Hematology|September 6, 2015
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cellsShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
Cancer Science|October 29, 2017
Clinical significance of tryptophan catabolism in Hodgkin lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
British Journal of Haematology|August 18, 2021
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Haematologica|August 5, 2018
Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphomaShiori Kinoshita, Takashi Ishida, Asahi Ito, et al.
Cancer Science|September 6, 2008
Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myelomaHiroki Yano, Satoshi Kayukawa, Shinsuke Iida, et al.
The American Journal of Pathology|April 12, 2002
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular featuresHiroshi Inagaki, John K C Chan, Josephine W M Ng, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Blood|January 24, 2020
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphomaRegina Wan Ju Wong, Tze King Tan, Stella Amanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infectionKiyoaki Ito, Yasuhito Tanaka, Etsuro Orito, et al.
Cancer Science|June 8, 2018
Current state of therapeutic development for rare cancers in Japan, and proposals for improvementAkira Kawai, Toshio Goto, Tatsuhiro Shibata, et al.
Journal of Virological Methods|May 22, 2003
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase supportHideaki Kato, Etsuro Orito, Fuminaka Sugauchi, et al.
International Journal of Hematology|September 6, 2015
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cellsShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
Cancer Science|October 29, 2017
Clinical significance of tryptophan catabolism in Hodgkin lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
British Journal of Haematology|August 18, 2021
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Haematologica|August 5, 2018
Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphomaShiori Kinoshita, Takashi Ishida, Asahi Ito, et al.
Cancer Science|September 6, 2008
Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myelomaHiroki Yano, Satoshi Kayukawa, Shinsuke Iida, et al.
The American Journal of Pathology|April 12, 2002
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular featuresHiroshi Inagaki, John K C Chan, Josephine W M Ng, et al.
Pageof 34